Submitted by Anonymous (not verified) on 30 January 2024 - 16:21
Orphan designation: 5-(3,4-Dichloro-phenyl)-N-((1R,2R)-2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide Treatment of Alport syndrome, 20/06/2023 Positive
Source:
